Products & Reviews

A transformative imaging solution that enables comprehensive analysis of cellular phenotypes and their interrelationships.

Production-scale throughput with exquisite single-cell sensitivity and consistent results

The next-generation mass cytometer, CyTOF XT™, redefines high-parameter cytometry with advances in automation, throughput, time to results and total cost of ownership. Built to simplify the design and execution of deep cell profiling studies, CyTOF XT standardizes sample analysis with reproducible workflows and automation to accelerate novel therapeutic development and improve human health.

Maintain sample identity throughout the workflow  

Reveal the molecular signatures of tumor immune responses

Conjugate IgG antibodies with your choice of up to 10 metals, with each kit containing enough material to conjugate 40 antibodies in 100 µg amounts.  

Targeted NGS library preparation, gene expression and genotyping. Increase productivity and efficiency with automated, cost-effective, and easy-to-use workflows for targeted DNA next-generation sequencing (NGS) library preparation, gene expression analysis and genotyping by allele-specific PCR.

Automated platform for single-cell omics and multi-omic research using solid-state microfluidics. C1 with integrated fluidic circuits (IFCs) enables the preparation of single-cell templates for total RNA sequencing and multi-omic applications such as preparing mRNA and DNA and mRNA and protein from the same isolated and imaged single cell.

Transform your laboratory productivity with nanoscale automation delivering substantial cost and operational savings for RNA-Seq library preparation.

Confidently analyze multiple somatic variants with a flexible, automated NGS workflow

Bioinformatics and Protein Array Services

Profiling against cancer antigens. Using the CTA Protein Array, Sengenics can quantify autoantibodies against more than 200 clinically relevant cancer testis antigens. These are tumor antigens normally expressed in germ cells but not in adult somatic tissues. In cancers, this regulation can be disrupted, resulting in CTA expression in tumors. The CTA array is ideal for research related to cancer immunotherapy.

Cancer drug screening and discovery. The OncoRex p53 Cancer Array provides a biologically relevant screening tool since all p53 variants are correctly folded and functional using the patented KREX ® protein folding technology. Using the array, Sengenics can screen your therapeutic antibodies and protein binding compounds against more than 100 p53 wildtype and mutant variants by measuring their impact on DNA binding as a func…

The i-Ome Discovery Protein Array uses the patented KREX® protein folding technology to enable accurate and reproducible profiling of patient samples against more than 1800 carefully selected full-length, properly folded proteins. Curated content focused on known and potential autoantigens helps facilitate biomarker discovery with significantly lower false discovery rates and smaller sample sizes than other technologies. The…

The future of spatial biology is here

Autoimmune disease autoantibody screening. Using the Pan-Autoimmune Protein Array 1.0, Sengenics can screen autoantibodies against more than 100 clinically relevant antigens in a wide range of autoimmune diseases. The Pan-Autoimmune Protein Array 1.0 service is ideal for focused autoimmune disease research.

The SomaScan Assay Services is a highly multiplexed, sensitive, quantitative, and reproducible protein profiling technology for discovering biomarkers in drug discovery, pre-clinical and clinical drug development across a wide range of diseases.

The SomaScan Assay Services is a highly multiplexed, sensitive, quantitative, and reproducible protein profiling technology for discovering biomarkers in drug discovery, pre-clinical and clinical drug development across a wide range of diseases.